PMS报告模板(英文).docx

上传人:王** 文档编号:585254 上传时间:2023-12-07 格式:DOCX 页数:6 大小:25.55KB
下载 相关 举报
PMS报告模板(英文).docx_第1页
第1页 / 共6页
PMS报告模板(英文).docx_第2页
第2页 / 共6页
PMS报告模板(英文).docx_第3页
第3页 / 共6页
PMS报告模板(英文).docx_第4页
第4页 / 共6页
PMS报告模板(英文).docx_第5页
第5页 / 共6页
PMS报告模板(英文).docx_第6页
第6页 / 共6页
亲,该文档总共6页,全部预览完了,如果喜欢就下载吧!
资源描述

《PMS报告模板(英文).docx》由会员分享,可在线阅读,更多相关《PMS报告模板(英文).docx(6页珍藏版)》请在优知文库上搜索。

1、Post-MarketSurveillance(PMS)/RiskManagementPlanTemplateTMP-031(ParentProcedureSYS-019)Version:aD2Effective:Author:M.WalkerPage:1of6Purpose:Todefinetheprocessandfrequencyofactivitiesforgatheringproductionandpostproductiondataasaninputintotheclinicalevaluationprocess(SYS-041)andriskmanagementprocess(S

2、YS-010).Scope:Thescopeofthispost-marketsurveillanceplanislimitedtotheProductFamilyNameduringtheperiodofearliestdatetolatestdate.Thepost-marketsurveillancesystemreferredtoinArticle83ofRegulation(EU)2017/745shallbebasedonapost-marketsurveillanceplan,therequirementsforwhicharesetoutinSection1.1ofAnnexI

3、II.Fordevicesotherthancustom-madedevices,thepost-marketsurveillanceplanshallbepartofthetechnicaldocumentationspecifiedinAnnexII.Thisplanalsoaddressestheproductionandpost-productionactivitiesrequiredaspartoftheriskmanagementprocessasdefinedinISO14971:2019,Clause10.Note:IfdifferentPMSandRiskManagement

4、inputscoverdifferentperiodsoftime,thenthisshouldbeclarifiedinthePMSreports(TMP-032)andRiskManagementreports(TMP-027).Oftenatableisidealtocommunicatethisinformation.Thesetworeporttemplatesmayalsobecombinedintoasinglereport.Responsibilities&Authorities:ThetableinthePMSinputssectiondefinesthepersonnelt

5、hatareresponsibleforgatheringeachtypeofPMSdataforProductFamilyName.Eachpersonisresponsibleforgatheringthedata,summarizingthatdata,writingabriefdiscussionofthedataanalysisanddocumentingaconclusionthatstateswhetherthedatawarrantsupdatingthePMSreportatthistimeortocontinuegatheringdatauntilthenextcyclei

6、scompleted.Evenifthereisnonewclinicaldatagatheredduringtheperiod,theclinicalevaluationreportstillrequiresupdatingtheliteraturesearch,gatheringofcomplaintdata,andIftheliteraturesearchconcludesthatthereisnonewclinicaldataavailable,documentboththemethodologyandtheresultsofthesearch.Iftherearenonewrisks

7、identifiedandthedatasuggeststhatnochangestothecurrentriskanalysisareneeded,thentheriskanalysismaynotneedtobeupdatedeither,butdocumenttheactivitiesthatledtothatconclusion.Therecommendedfrequencyforthenextsummaryofdatashouldbeindicatedintheconclusionaswell.TechnicalDocumentationonPost-MarketSurveillan

8、ceThetechnicaldocumentationonpost-marketsurveillancetobedrawnupbytheCompanyNameinaccordancewithReg.(EU)2017/745,Articles83to86shallbepresentedinaclear,organized,readilysearchableandunambiguousmanner.ThePost-MarketSurveillancePlanshallbepartoftheTechnicalDocumentation.Post-MarketSurveillance(PMS)/Ris

9、kManagementPlanTemplateTMP-031(ParentProcedureSYS-019)Version:aD2Effective:Author:M.WalkerPage:2of6AsrequiredwithinAnnexIII,Section1.1a)ofReg.(EU)2017/745thePost-MarketSurveillancePlanshalladdressthecollectionandutilizationofavailableinformation,inparticular: informationconcerningseriousincidents,in

10、cludinginformationfromPeriodicSafetyUpdateReports(PSUR)s(TMP-033)jandfieldsafetycorrectiveactions; recordsreferringtonon-seriousincidentsanddataonanyundesirablesideeffects; informationfromtrendreporting; relevantspecialistortechnicalliterature,databasesand/orregisters; information,includingfeedbacks

11、andcomplaints,providedbyusers,distributorsandimporters;and publiclyavailableinformationaboutsimilarmedicaldevices.AsrequiredwithinAnnexIII,Section1.1b)ofReg.(EU)2017/745thePost-MarketSurveillancePlanshallcoveratleast: aproactiveandsystematicprocesstocollectanyinformationreferredtoaboveinpoint(a).The

12、processshallallowacorrectcharacterizationoftheperformanceofthedevicesandshallalsoallowacomparisontobemadebetweenthedeviceandsimilarproductsavailableonthemarket; effectiveandappropriatemethodsandprocessestoassessthecollecteddata; suitableindicatorsandthresholdvaluesthatshallbeusedinthecontinuousreass

13、essmentofthebenefit-riskanalysisandoftheriskmanagementasreferredtoinReg.(EU)2017/745,Section3ofAnnexI; effectiveandappropriatemethodsandtoolstoinvestigatecomplaintsandanalyzemarket-relatedexperiencecollectedinthefield; methodsandprotocolstomanagetheeventssubjecttothetrendreportasprovidedforinReg.(EU

14、)2017/745,Article88,includingthemethodsandprotocolstobeusedtoestablishanystatisticallysignificantincreaseinthefrequencyorseverityofincidentsaswellastheobservationperiod; methodsandprotocolstocommunicateeffectivelywithcompetentauthorities,notifiedbodies,economicoperatorsandusers; Referencetoprocedure

15、stofulfiltheCompanyName,sobligationslaiddowninReg.(EU)2017/745,Articles83,84and86; systematicprocedurestoidentifyandinitiateappropriatemeasuresincludingcorrectiveactions; effectivetoolstotraceandidentifydevicesforwhichcorrectiveactionsmightbenecessary;and aPost-MarketClinicalFollow-up(PMCF)Planasref

16、erredtoinReg.(EU)2017/745,PartBofAnnexXIV,orajustificationastowhyaPMCFisnotapplicable(seePMCFPlanChecklist-TMP-008)Post-MarketSurveillance(PMS)/RiskManagementPlanTemplateTMP-031(ParentProcedureSYS-019)Version:aD2Effective:Author:M.WalkerPage:3of6AsrequiredwithinAnnexIII,Section1.2ofReg.(EU)2017/745thePSUR(TMP-033)referredtoinArticle86andthepost-marketsurveillancereportreferre

展开阅读全文
相关资源
猜你喜欢
相关搜索

当前位置:首页 > IT计算机 > 多媒体

copyright@ 2008-2023 yzwku网站版权所有

经营许可证编号:宁ICP备2022001189号-2

本站为文档C2C交易模式,即用户上传的文档直接被用户下载,本站只是中间服务平台,本站所有文档下载所得的收益归上传人(含作者)所有。装配图网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。若文档所含内容侵犯了您的版权或隐私,请立即通知装配图网,我们立即给予删除!